Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis
Year: 2022
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: BACKGROUND: The importance of patient-reported outcome measurement in chronic kidney disease (CKD) populations has been established. However, there remains a lack of research that has synthesised data around CKD-specific symptom and health-related quality of life (HRQOL) burden globally, to inform focused measurement of the most relevant patient-important information in a way that minimises patient burden. The aim of this review was to synthesise symptom prevalence/severity and HRQOL data across the following CKD clinical groups globally: (1) stage 1-5 and not on renal replacement therapy (RRT), (2) receiving dialysis, or (3) in receipt of a kidney transplant. METHODS AND FINDINGS: MEDLINE, PsycINFO, and CINAHL were searched for English-language cross-sectional/longitudinal studies reporting prevalence and/or severity of symptoms and/or HRQOL in CKD, published between January 2000 and September 2021, including adult patients with CKD, and measuring symptom prevalence/severity and/or HRQOL using a patient-reported outcome measure (PROM). Random effects meta-analyses were used to pool data, stratified by CKD group: not on RRT, receiving dialysis, or in receipt of a kidney transplant. Methodological quality of included studies was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data, and an exploration of publication bias performed. The search identified 1,529 studies, of which 449, with 199,147 participants from 62 countries, were included in the analysis. Studies used 67 different symptom and HRQOL outcome measures, which provided data on 68 reported symptoms. Random effects meta-analyses highlighted the considerable symptom and HRQOL burden associated with CKD, with fatigue particularly prevalent, both in patients not on RRT (14 studies, 4,139 participants: 70%, 95% CI 60%-79%) and those receiving dialysis (21 studies, 2,943 participants: 70%, 95% CI 64%-76%). A number of symptoms were significantly (p < 0.05 after adjustment for multiple testing) less prevalent and/or less severe within the post-transplantation population, which may suggest attribution to CKD (fatigue, depression, itching, poor mobility, poor sleep, and dry mouth). Quality of life was commonly lower in patients on dialysis (36-Item Short Form Health Survey [SF-36] Mental Component Summary [MCS] 45.7 [95% CI 45.5-45.8]; SF-36 Physical Component Summary [PCS] 35.5 [95% CI 35.3-35.6]; 91 studies, 32,105 participants for MCS and PCS) than in other CKD populations (patients not on RRT: SF-36 MCS 66.6 [95% CI 66.5-66.6], p = 0.002; PCS 66.3 [95% CI 66.2-66.4], p = 0.002; 39 studies, 24,600 participants; transplant: MCS 50.0 [95% CI 49.9-50.1], p = 0.002; PCS 48.0 [95% CI 47.9-48.1], p = 0.002; 39 studies, 9,664 participants). Limitations of the analysis are the relatively few studies contributing to symptom severity estimates and inconsistent use of PROMs (different measures and time points) across the included literature, which hindered interpretation. CONCLUSIONS: The main findings highlight the considerable symptom and HRQOL burden associated with CKD. The synthesis provides a detailed overview of the symptom/HRQOL profile across clinical groups, which may support healthcare professionals when discussing, measuring, and managing the potential treatment burden associated with CKD. PROTOCOL REGISTRATION: PROSPERO CRD42020164737.
Source: PLoS Medicine
Authors: Benjamin R. Fletcher(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing), Sarah Damery(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing), Olalekan Lee Aiyegbusi(Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing), Nicola Anderson(Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing), Melanie Calvert(Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing), Paul Cockwell(Conceptualization, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing), James Ferguson(Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing), Mike Horton(Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing), Muirne C. S. Paap(Conceptualization, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing), Chris Sidey-Gibbons(Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing), Anita Slade(Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Neil Turner(Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing), Derek Kyte(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing)
Institutions: University of Birmingham, National Institute for Health and Care Research, NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, NIHR Surgical Reconstruction and Microbiology Research Centre, University of Leeds, University of Groningen, The University of Texas MD Anderson Cancer Center, Centre for Inflammation Research, University of Edinburgh, University of Worcester
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,300
Funders: Gilead Sciences, Patient-Centered Outcomes Research Institute, Macmillan Cancer Support, University Hospitals Birmingham NHS Foundation Trust, UK Research and Innovation, National Institute for Health and Care Research, Kidney Research UK, University of Birmingham, Astellas Pharma, Surgical Reconstruction and Microbiology Research Centre, Innovate UK, Birmingham Biomedical Research Centre, National Institute for Health Research Applied Research Collaboration West, UCB Pharma, Daiichi Sankyo Europe, Health Data Research UK
Awards: G2102272463, The use of an electronic Patient-Reported Outcome Measure (ePROM) in the Management of Patients with Advanced Chronic Kidney Disease – A Pilot/Feasibility Study for a Randomised Controlled Trial., Using electronic Patient-Reported Outcome Measures (ePROMs) to promote quality of care and safety in the management of patients with End Stage Kidney Disease requiring treatment with Haemodialysis (HD) in research and routine clinical settings: a mixed-methods study., G7184273353, G8331554054, NIHR Senior Investigator Award
OpenAlex ID: W4223633541
